Koç, E. Et Al. 2023. Methylprednisolone 100 mg tablet formulation with pea protein: experimental approaches over intestinal permeability and cytotoxicity. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY , vol.1, no.1 , 1-12.

Koç, E., Çalık, H., Çiftçi, F., Korkmaz, S., & Çakır Koç, R., (2023). Methylprednisolone 100 mg tablet formulation with pea protein: experimental approaches over intestinal permeability and cytotoxicity. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY , vol.1, no.1, 1-12.

Koç, Erhan Et Al. "Methylprednisolone 100 mg tablet formulation with pea protein: experimental approaches over intestinal permeability and cytotoxicity," DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY , vol.1, no.1, 1-12, 2023

Koç, Erhan Et Al. "Methylprednisolone 100 mg tablet formulation with pea protein: experimental approaches over intestinal permeability and cytotoxicity." DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY , vol.1, no.1, pp.1-12, 2023

Koç, E. Et Al. (2023) . "Methylprednisolone 100 mg tablet formulation with pea protein: experimental approaches over intestinal permeability and cytotoxicity." DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY , vol.1, no.1, pp.1-12.

@article{article, author={Erhan Koç Et Al. }, title={Methylprednisolone 100 mg tablet formulation with pea protein: experimental approaches over intestinal permeability and cytotoxicity}, journal={DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY}, year=2023, pages={1-12} }